美农生物
(301156)
| 流通市值:13.50亿 | | | 总市值:21.01亿 |
| 流通股本:1.18亿 | | | 总股本:1.84亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 138,386,025.87 | 166,948,848.33 | 186,447,049.93 | 204,658,327.68 |
| 结算备付金 | - | 0 | 0 | 0 |
| 拆出资金 | - | 0 | 0 | 0 |
| 交易性金融资产 | - | 0 | 0 | 0 |
| 衍生金融资产 | - | 0 | 0 | 0 |
| 应收票据及应收账款 | 119,260,393.44 | 123,523,280.63 | 118,104,407.17 | 99,234,831.37 |
| 其中:应收票据 | 1,021,000 | 285,000 | 209,796.59 | 482,083 |
| 应收账款 | 118,239,393.44 | 123,238,280.63 | 117,894,610.58 | 98,752,748.37 |
| 应收款项融资 | 135,000 | 798,048.38 | 173,570.41 | 0 |
| 预付款项 | 15,070,316.25 | 19,390,386.02 | 14,794,758.25 | 5,449,278.26 |
| 应收保费 | - | 0 | 0 | 0 |
| 应收分保账款 | - | 0 | 0 | 0 |
| 应收分保合同准备金 | - | 0 | 0 | 0 |
| 其他应收款合计 | 488,769.49 | 889,275.14 | 379,568.1 | 371,900.1 |
| 其中:应收利息 | - | 0 | 0 | 0 |
| 应收股利 | - | 0 | 0 | 0 |
| 买入返售金融资产 | - | 0 | 0 | 0 |
| 存货 | 114,183,492.59 | 114,906,035.24 | 74,065,880.58 | 71,490,936.25 |
| 合同资产 | - | 0 | 0 | 0 |
| 一年内到期的非流动资产 | - | 0 | 0 | 0 |
| 其他流动资产 | 27,270,770.73 | 25,194,178.82 | 18,385,800.62 | 12,558,347.17 |
| 流动资产合计 | 414,794,768.37 | 451,650,052.56 | 412,351,035.06 | 393,763,620.83 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | 0 | 0 | 0 |
| 债权投资 | - | 0 | 0 | 0 |
| 其他债权投资 | - | 0 | 0 | 0 |
| 长期应收款 | - | 0 | 0 | 0 |
| 长期股权投资 | 23,555,681.14 | 23,602,970.13 | 22,881,504.22 | 22,460,994.25 |
| 其他权益工具投资 | - | 0 | 0 | 0 |
| 其他非流动金融资产 | 2,476,306.14 | 3,001,213.76 | 3,064,472.56 | 2,701,916.12 |
| 投资性房地产 | - | 0 | 0 | 0 |
| 固定资产 | 291,383,077.56 | 295,756,866.68 | 301,851,512.14 | 190,763,156.37 |
| 在建工程 | 8,667,165.02 | 8,431,618.91 | 9,387,415.23 | 99,458,490.63 |
| 生产性生物资产 | - | 0 | 0 | 0 |
| 油气资产 | - | 0 | 0 | 0 |
| 使用权资产 | 143,088.96 | 158,987.79 | 174,886.62 | 190,785.45 |
| 无形资产 | 50,283,078.07 | 65,004,164.2 | 64,976,986.07 | 65,303,057.65 |
| 开发支出 | - | 0 | 0 | 0 |
| 商誉 | - | 0 | 0 | 0 |
| 长期待摊费用 | 6,860,723.4 | 7,236,872.46 | 7,481,307.75 | 4,091,003.54 |
| 递延所得税资产 | 10,087,335.5 | 8,162,821.62 | 6,863,983 | 4,270,607.65 |
| 其他非流动资产 | 1,359,290 | 545,700 | 8,100 | 693,958 |
| 非流动资产合计 | 394,815,745.79 | 411,901,215.55 | 416,690,167.59 | 389,933,969.66 |
| 资产总计 | 809,610,514.16 | 863,551,268.11 | 829,041,202.65 | 783,697,590.49 |
| 流动负债: | | | | |
| 短期借款 | - | 0 | 0 | 0 |
| 向中央银行借款 | - | 0 | 0 | 0 |
| 吸收存款及同业存放 | - | 0 | 0 | 0 |
| 拆入资金 | - | 0 | 0 | 0 |
| 交易性金融负债 | - | 0 | 0 | 0 |
| 衍生金融负债 | - | 0 | 0 | 0 |
| 应付票据及应付账款 | 59,978,312.39 | 97,829,278.33 | 54,234,110.95 | 31,964,427.14 |
| 其中:应付票据 | 9,911,943.3 | 8,664,147.9 | 0 | 0 |
| 应付账款 | 50,066,369.09 | 89,165,130.43 | 54,234,110.95 | 31,964,427.14 |
| 预收款项 | - | 0 | 0 | 0 |
| 合同负债 | 1,398,732.22 | 1,102,317.29 | 531,147.6 | 3,308,339.71 |
| 卖出回购金融资产款 | - | 0 | 0 | 0 |
| 应付手续费及佣金 | - | 0 | 0 | 0 |
| 应付职工薪酬 | 12,585,459.79 | 7,104,883.2 | 19,486,508.95 | 13,419,326.46 |
| 应交税费 | 2,545,392.39 | 5,851,489.13 | 6,658,317.91 | 4,614,634.01 |
| 其他应付款合计 | 1,883,795.09 | 1,004,684.92 | 15,179,615.21 | 1,399,242.23 |
| 其中:应付利息 | - | 0 | 0 | 0 |
| 应付股利 | - | 0 | 14,078,467.5 | 0 |
| 应付分保账款 | - | 0 | 0 | 0 |
| 保险合同准备金 | - | 0 | 0 | 0 |
| 代理买卖证券款 | - | 0 | 0 | 0 |
| 代理承销证券款 | - | 0 | 0 | 0 |
| 一年内到期的非流动负债 | 77,298.48 | 76,466.9 | 75,644.27 | 74,830.49 |
| 其他流动负债 | 298,017.21 | 21,803.03 | 210,559.06 | 57,209.75 |
| 流动负债合计 | 78,767,007.57 | 112,990,922.8 | 96,375,903.95 | 54,838,009.79 |
| 非流动负债: | | | | |
| 长期借款 | - | 0 | 0 | 0 |
| 应付债券 | - | 0 | 0 | 0 |
| 优先股 | - | 0 | 0 | 0 |
| 永续债 | - | 0 | 0 | 0 |
| 租赁负债 | 80,716.22 | 79,847.88 | 78,988.87 | 78,139.11 |
| 长期应付款 | - | 0 | 0 | 0 |
| 长期应付职工薪酬 | - | 0 | 0 | 0 |
| 预计负债 | - | 0 | 0 | 0 |
| 递延收益 | 1,936,249.22 | 2,445,016.07 | 2,345,556.62 | 2,504,883.77 |
| 递延所得税负债 | - | 0 | 0 | 0 |
| 其他非流动负债 | - | 0 | 0 | 0 |
| 非流动负债合计 | 2,016,965.44 | 2,524,863.95 | 2,424,545.49 | 2,583,022.88 |
| 负债合计 | 80,783,973.01 | 115,515,786.75 | 98,800,449.44 | 57,421,032.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 183,020,077 | 140,784,675 | 140,784,675 | 140,784,675 |
| 其他权益工具 | - | 0 | 0 | 0 |
| 优先股 | - | 0 | 0 | 0 |
| 永续债 | - | 0 | 0 | 0 |
| 资本公积 | 282,409,240.79 | 320,305,393.77 | 315,962,928.83 | 311,812,612.23 |
| 减:库存股 | - | 0 | 0 | 0 |
| 其他综合收益 | - | 0 | 0 | 0 |
| 专项储备 | - | 0 | 0 | 0 |
| 盈余公积 | 47,559,547.96 | 47,559,547.96 | 47,559,547.96 | 46,403,169.73 |
| 一般风险准备 | - | 0 | 0 | 0 |
| 未分配利润 | 215,837,675.4 | 239,385,864.63 | 225,933,601.42 | 227,276,100.86 |
| 归属于母公司股东权益合计 | 728,826,541.15 | 748,035,481.36 | 730,240,753.21 | 726,276,557.82 |
| 少数股东权益 | - | 0 | 0 | 0 |
| 股东权益合计 | 728,826,541.15 | 748,035,481.36 | 730,240,753.21 | 726,276,557.82 |
| 负债和股东权益合计 | 809,610,514.16 | 863,551,268.11 | 829,041,202.65 | 783,697,590.49 |
| 公告日期 | 2026-08-27 | 2026-04-28 | 2026-04-28 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |